Post-Market Surveillance
The proactive collection and analysis of real-world data on a device after it has been placed on the market.
Post-Market Surveillance (PMS) ensures continuous monitoring of device safety, performance, and clinical benefit throughout its lifecycle. Manufacturers must use PMS data to update risk analyses, inform clinical evaluations, and report adverse events to regulatory bodies like the FDA or through EUDAMED.